OGI
Organigram Global Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$1.16
−1.28%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 309.1M | 186.1M | 159.8M | 149.2M | 145.8M |
| Cost of Revenue | 196.2M | 179.3M | 112.3M | 114.1M | 114.2M |
| Gross Profit | 113.0M | 6.8M | 47.5M | 35.1M | 31.6M |
| Operating Expenses | |||||
| R&D Expense | 9.5M | 10.9M | 11.2M | 12.2M | 6.0M |
| SG&A Expense | 103.6M | 86.9M | 67.2M | 71.7M | 59.2M |
| General & Admin Expense | 64.9M | 55.8M | 47.4M | 53.8M | 42.4M |
| Selling & Marketing Expense | 38.7M | 31.1M | 19.9M | 17.9M | 16.9M |
| Other Expenses | 6.6M | (27.6M) | 3.9M | 193.9M | 5.1M |
| Total Operating Expenses | 119.7M | 70.2M | 82.3M | 277.8M | 70.3M |
| Cost and Expenses | 315.9M | 249.5M | 194.6M | 391.9M | 184.6M |
| Operating Income (EBIT) | (6.7M) | (63.4M) | (34.8M) | (242.7M) | (38.8M) |
| Non-Operating | |||||
| Interest Income | 405.7K | 825.7K | — | 3.4M | — |
| Interest Expense | 488.8K | — | — | — | 429.0K |
| Net Interest Income | (83.1K) | 825.7K | — | 3.4M | (429.0K) |
| Other Non-Op Income/Expense | 88.0M | 35.7M | (10.7M) | 9.7M | 24.4M |
| Non-Operating Income (excl Interest) | — | (35.7M) | — | (193.9M) | (24.8M) |
| EBT (Pre-Tax Income) | 81.3M | (27.7M) | (45.4M) | (233.0M) | (14.4M) |
| Income Tax Expense | (5.4M) | (9.9M) | — | (3.5M) | (88.0K) |
| Bottom Line | |||||
| Net Income | 86.6M | (17.8M) | (45.4M) | (229.5M) | (14.3M) |
| Earnings from Cont. Ops | 86.6M | (17.8M) | (45.4M) | (229.5M) | (14.3M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 86.6M | (17.8M) | (45.4M) | (229.5M) | (14.3M) |
| Per Share | |||||
| Basic EPS | $0.63 | ($0.14) | ($0.48) | ($2.82) | ($0.18) |
| Diluted EPS | $0.63 | ($0.14) | ($0.48) | ($2.82) | ($0.18) |
| Revenue Per Share | $2.26 | $1.46 | $1.68 | $1.84 | $1.89 |
| Shares | |||||
| Basic Shares Outstanding | 136.5M | 127.7M | 95.3M | 81.3M | 77.2M |
| Diluted Shares Outstanding | 136.5M | 127.7M | 95.3M | 81.3M | 77.2M |
| Profitability Metrics | |||||
| EBITDA | 19.1M | (14.8M) | (22.7M) | (25.4M) | 11.0M |
| D&A | 25.8M | 12.9M | 12.1M | 23.4M | 24.9M |
| EBIT | (6.7M) | (27.7M) | (34.8M) | (48.8M) | (13.9M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026